Colaford and Primwak take fundamentally different approaches to joint health. We break down the clinical rationale behind each ingredient — from L-Arginine 500mg and Sodium Hyaluronate to Curcumin 100mg and Collagen Type II — and how they complement each other.
Joint degeneration is multi-factorial — cartilage loss, synovial fluid degradation, inflammation, poor microcirculation, and oxidative stress all contribute simultaneously. Colaford addresses the structural and vascular aspects: L-Arginine 500mg + Chondroitin Sulfate 200mg + Collagen Peptides Type II 40mg + Rosehip Extract 50mg + Glucosamine Sulphate + Boswellia Serrata Extract 50mg + Sodium Hyaluronate 30mg + Vitamin C 12.5mg. Primwak targets inflammation and cartilage repair with natural actives: Collagen Peptide Blend 300mg (Types I, II, III, IX, X, XII) + Ascorbic Acid 40mg + Curcumin 100mg + Ginger Extract 100mg + Sodium Hyaluronate 25mg + Vitamin D3 400IU + Vitamin E 10mg.
L-Arginine 500mg: The Overlooked Joint Nutrient in Colaford
L-Arginine is the precursor to nitric oxide (NO), which regulates microvascular function. Joint cartilage is avascular — it receives all nutrition through diffusion from synovial fluid. NO-mediated vasodilation in periarticular tissues significantly enhances nutrient delivery to the cartilage zone. This is why L-Arginine is not merely a 'gym supplement' but a clinically meaningful component in joint therapy, particularly in patients with diabetes or cardiovascular disease where microvascular function is already compromised.
Sodium Hyaluronate: The Joint's Natural Lubricant
Sodium Hyaluronate (HA) is the primary component of synovial fluid, responsible for joint lubrication and shock absorption. In osteoarthritic joints, both HA concentration and molecular weight decrease, leading to increased friction, pain, and accelerated cartilage wear. Colaford provides 30mg and Primwak 25mg of Sodium Hyaluronate — consistent daily oral supplementation has demonstrated improvement in pain scores and reduced NSAID requirements over 12 weeks of use.
Curcumin + Boswellia: Multi-Pathway Anti-Inflammatory Coverage
Primwak's Curcumin 100mg inhibits COX-2 and NF-κB pathways — the same molecular targets as NSAIDs, without GI toxicity. Colaford's Boswellia Serrata 50mg inhibits 5-lipoxygenase (5-LOX), the enzyme producing leukotriene B4, a potent mediator of joint inflammation not addressed by NSAIDs at all. Together they provide genuinely complementary anti-inflammatory coverage.
- check_circleCollagen Type II 40mg (Colaford): Provides amino acid substrate for articular cartilage matrix synthesis
- check_circleChondroitin Sulfate 200mg: Inhibits cartilage-degrading matrix metalloproteinases (MMPs)
- check_circleGlucosamine Sulphate: Stimulates proteoglycan synthesis — the shock-absorbing component of cartilage
- check_circleCollagen Peptide Blend 300mg (Primwak): Types I, II, III, IX, X, XII — covers all connective tissue types
- check_circleGinger Extract 100mg: COX and LOX dual inhibitor with additional gastroprotective effect
format_quote"Collagen supplementation requires patience — the cartilage turnover cycle is 3–6 months. Short trials of 4–6 weeks are insufficient to measure clinical benefit. I prescribe Colaford and Primwak for 6–10 week courses at minimum." — Orthopaedic Surgeon